Hoosiers Work For Health Partners

Bayer
Chambers of Commerce: Bloomington, Carmel, Decatur, Greater Indianapolis, Fort Wayne, Indiana Hispanic and Indiana State
The Cities of Bicknell, Bloomington, Hammond, Huntington, Linton, Loogootee, Mitchell, Oakland City, Petersburg, Washington and Vincennes
Epilepsy Foundation of Kentuckiana
Goodwill Industries of Indiana
Eli Lilly and Company
Indiana Association of Cities and Towns (IACT)
Indiana Economic Development Association (IDEA)
Indiana Health Industry Forum
Indiana Latino Institute
Indiana Minority Supplier Diversity Council
Indiana Sheet Metal Workers
Indiana State Dept. of Health Diabetes Prevention and Control Program
Indiana Urban and Rural Health Network
Indianapolis Economic Development
Indiana Minority Health Coalition
Jackson County United Way
Jefferson County United Way, Inc.
Mental Health America of Indiana
National Alliance on Mental Illness (NAMI) Indiana
National Kidney Foundation of Indiana
One Southern Indiana
Pfizer
PhRMA
Roche Diagnostics
United Way of Central Indiana

Industry Impact

America’s biopharmaceutical industry helps to research, manufacture, distribute and promote innovative therapies that make a critical difference in the lives of millions of people. In the last ten years, scientists have discovered and developed more than 300 completely new medicines, vaccines and biologics approved by the Federal Drug Administration (FDA).

The value of this sector, however, extends beyond life-enhancing advancements in medicine and includes great contributions to Indiana’s economy. Biopharmaceutical companies generate tax revenue, create high-paying jobs and provide growth opportunities for related industries. In fact:

• Biopharmaceutical companies supported a total of 87,675 jobs in Indiana in 2008 - 14,442 directly in the sector and 73,234 in other sectors.
• Direct biopharmaceutical wages in Indiana were estimated to be $1.5 billion in 2008, resulting in an estimated $383.6 million in federal taxes and $46.8 million in state taxes.
• In 2010, U.S. scientists and researchers were conducting 15,134 studies to develop medicines targeting cancers, rare diseases, and other important conditions. In Indiana, there were 1,643 active trials.
• In Indiana, biopharmaceutical companies invested $2.0 billion in research and development of new medicines in 2008.

In addition, many biopharmaceutical companies provide philanthropic assistance in their local communities through support of access to affordable products, education, social services, arts and other community needs.

To learn more, download the fact sheet (PDF): The Biopharmaceutical Sector’s Impact on the Economy of Indiana.